This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Metro International Biotech, LLC. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Karen Lavery
Introduction
Karen Lavery is a prominent inventor based in Worcester, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-viral compounds and methods for treating inflammation. With a total of 3 patents to her name, Lavery's work is paving the way for advancements in medical treatments.
Latest Patents
Lavery's latest patents include groundbreaking research on anti-viral compounds and methods of use. This patent focuses on compounds and compositions designed to treat diseases caused by viral infections, including coronaviruses such as SARS, MERS, and COVID-19, as well as HIV and hepatitis-associated viruses. The compounds feature an 'NMN-like' moiety linked to another biologically active moiety, which promotes increased intracellular levels of nicotinamide adenine dinucleotide (NAD) in cells and tissues. Additionally, she has developed compositions for the treatment of inflammation, which involve methods for identifying agents that can help treat and prevent inflammation-related disorders by increasing NAD+ levels.
Career Highlights
Lavery's career is marked by her dedication to innovative research and development in biotechnology. Her work has not only contributed to scientific knowledge but also holds the potential for real-world applications in treating viral infections and inflammatory conditions.
Collaborations
Throughout her career, Lavery has collaborated with notable colleagues, including Matthew Baevsky and David J Livingston. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Karen Lavery's innovative contributions to biotechnology demonstrate her commitment to advancing medical treatments through her patented inventions. Her work continues to inspire and pave the way for future research in combating viral infections and inflammation.